NASDAQ: BVSBioventus Inc Stock Ownership - Who owns Bioventus?
Insider buying vs selling
Have Bioventus Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William A. 1. Hawkins | Director | 2023-05-25 | 44,000 | $2.66 | $117.17kBuy |
| William A. 1. Hawkins | Director | 2023-05-24 | 44,000 | $2.69 | $118.40kBuy |
| Anthony P. Bihl Iii | Interim CEO | 2023-05-23 | 125,000 | $2.33 | $291.00kBuy |
| John A. Bartholdson | Director | 2023-05-22 | 178,998 | $2.08 | $372.32kBuy |
| John A. Bartholdson | Director | 2023-05-19 | 1,136,675 | $1.94 | $2.20MBuy |
| Katrina J. Church | SVP Chief Compliance Officer | 2023-04-03 | 117 | $1.07 | $125.19Sell |
| Mark Leonard Singleton | SVP CFO | 2023-03-24 | 6,044 | $1.27 | $7.68kSell |
| Kenneth Michael Reali | Chief Executive Officer | 2023-03-15 | 9,811 | $1.39 | $13.63kSell |
| Katrina J. Church | SVP Chief Compliance Officer | 2023-03-15 | 1,332 | $1.39 | $1.85kSell |
| Anthony Dadamio | SVP General Counsel | 2023-03-15 | 3,409 | $1.39 | $4.74kSell |
BVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BVS insiders and whales buy or sell their stock.
BVS Shareholders
What type of owners hold Bioventus Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Smith Nephew PLC | 21.12% | 16,534,814 | $46.63M | Insider |
| Martin P. Sutter | 16.65% | 13,033,024 | $36.75M | Insider |
| Ew Healthcare Partners Acquisition Fund LP | 16.64% | 13,021,324 | $36.72M | Insider |
| Essex Woodlands Management Inc | 15.45% | 12,096,702 | $34.11M | Institution |
| John A. Bartholdson | 7.56% | 5,916,712 | $16.69M | Insider |
| Nantahala Capital Management LLC | 6.61% | 5,173,469 | $14.59M | Institution |
| Juniper Investment Company LLC | 5.87% | 4,593,463 | $12.95M | Institution |
| Spindletop Healthcare Capital LP | 4.99% | 3,906,395 | $11.02M | Insider |
| Ampcf Holdings LLC | 4.16% | 3,255,332 | $9.18M | Insider |
| David J. Parker | 4.16% | 3,255,332 | $9.18M | Insider |
BVS vs Diagnostic & Research Stocks
Bioventus Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.